Association Between Genetic Polymorphisms and Type 2 Asthma in Children

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age3-14
SponsorGuangzhou Institute of Respiratory Disease

About this trial

To further understand the role of gene single nucleotide polymorphism (SNP) in the occurrence of type 2 inflammation-related asthma in children by analyzing the gene single nucleotide polymorphism (SNP), lung function and type 2 inflammation indicators of children diagnosed with asthma in outpatient and inpatient. To provide a theoretical basis for the study of personalized treatment and prevention strategies for asthma.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

All children with asthma diagnosis accord with the GINA in 2023 edition;

Other diseases that could cause wheezing and cough were excluded, such as acute laryngitis, diphtheria, congenital airway abnormalities, and tracheal foreign bodies;

In front of the hospital 2 weeks without antibiotics, systemic hormone medication history;

There were no other complications, such as congenital heart disease, pneumonia, gastroesophageal reflux disease, muscle dysplasia, etc.

Disqualifiers

Children who had taken immunosuppressants, antibiotics and other drugs for a long time before admission;

Children with primary immunodeficiency disease;

The children and their families failed to cooperate or refused the experimental observation.

Trial population

Children with asthma, aged 3-14 years, attending our hospital.

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

300 Participants
are grouped into 2 trial groups
Group A: Case group
Group B: Control group

Trial outcomes

Primary outcomes

1

type 2 inflammation indicators

Fraction of exhaled nitric oxide(FeNO)、Blood eosinophil count、Percentage of sputum eosinophils and Serum total immunoglobulin E

Time frame
Outpatient visits for the first time
2

pulmonary function indicators

Forced expiratory volume in one second(FEV1)、Forced vital capacity(FVC)、Ratio of forced expiratory volume in one second to forced vital capacity(FEV1/FVC) and Peak expiratory flow(PEF)

Time frame
Outpatient visits for the first time
3

single nucleotide polymorphism

Differences in SNPs of genes detected in children's blood samples

Time frame
Outpatient visits for the first time

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.